+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 14Years +
All Genders
ID07659756

Global Study on Atopic Dermatitis Tracking Treatment Patterns, Care Access, and Quality of Life Across Healthcare Systems

Led by Julia Tatjana Maul · Updated on 2026-06-22

9600

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting the Global Healthcare Study on Atopic Dermatitis GHSAD, an international observational study hosted by the University of Zurich. It investigates healthcare access, treatment patterns, disease severity, and quality of life in patients diagnosed with atopic dermatitis. The study aims to identify differences in healthcare delivery and outcomes across various healthcare systems by collecting standardized clinical data. This study uses a combined retrospective and prospective design, collecting data from routine clinical care and medical records starting from January 2020 through to the study conclusion. It focuses on patients with atopic dermatitis without administering specific treatments or interventions. Participants data will be collected at baseline and during follow-up visits every 6 to 12 months for up to 5 years. Researchers will assess disease severity using tools like the Eczema Area and Severity Index EASI and other measures including SCORAD, Dermatology Life Quality Index, Patient-Oriented Eczema Measure, Peak Pruritus Numerical Rating Scale, Physician Global Assessment, Body Surface Area, and patient-reported severity scales. The study involves reviewing medical records and quality of life assessments throughout this period.

CONDITIONS

Brief Title

Global Healthcare Study on Atopic Dermatitis

Research Team

J

Julia-Tatjana Maul, Prof. Dr. med.

J

Johannes Didaskalu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here